Table 1 Selected IR and NMR data for compounds 1–20
1H NMR,b δ (ppm), J (Hz)
IRa/cmϪ1
31P{1H}NMR,b
Complex
ν(C᎐O)
Ligand 1 or 3
Other
δ (ppm), J (Hz)
᎐
1
1Ј
2
1715s
1672m
1669s
1698s
2.13 [s, 3H, C(O)Me], 6.15 (br, 1H, NH)
2.30 [s, 3H, C(O)Me], OH not observed
2.18 [d, 3H, 4JPH = 3, C(O)Me], 2.24
(d, 3H, 2JPH = 13, PMe)
21.6
31.1
19.8
3
4
2.54 (d, 3H, 3JPH = 4.8, NMe), 2.74 [s, 3H,
C(O)Me]
55.1
2.10 [s, 3H, C(O)Me], 9.7 (br, 1H, NH)
(298 K); 2.06 [s, 3H, C(O)Me], 9.2 (d, 1H,
2JPH = 16, NH) (220 K)
2.87 (d, 6H, 4JPH = 2.8, NMe2), 3.99
(d, 2H, 4JPH = 6.9, NCH2) (298 K);
2.87 (s, br, 6H, NMe2), 3.98 (s, br, 2H,
NCH2) (220 K)
61.8 (br) (298 K)
60.7 (220 K)
4Ј
5
2.52 [s, 3H, C(O)Me], 12.9 (br, 1H, NH)
(220 K)
2.93 (s, br, 6H, NMe2), 4.07 (s, br, 2H,
NCH2) (220 K)
79.7 (220 K)
79.0c
1604s
1672s
1584s
2.43 [s, 3H, C(O)Me], 10.74 (br, 1H, NH)c
2.93 (d, 6H, 4JPH = 2.8, NMe2), 4.06
(d, 4JPH = 2.1, NCH2)c
6
2.38 [s, 3H, C(O)Me], 2.99 (d, 3H,
3JPH = 6.6, NMe)
2.85 (d, 6H, 4JPH = 3.0, NMe2), 4.03
(d, 2H, 4JPH = 2.4, NCH2)
85.8
7
2.56 [s, 3H, C(O)Me], 3.11 (d, 3H,
2.92 (d, 6H, 4JPH = 3.0, NMe2), 4.03
(d, 2H, 4JPH = 2.4, NCH2)
97.8
3JPH = 5.4, NMe)
8a
8b
9
1614s
1602s
2.40 [s, 3H, C(O)Me], 10.06 (br, 1H, NH)c
2.35 [s, 3H, C(O)Me], 10.23 (br, 1H, NH)
2.37 [s, 3H, C(O)Me], 8.88 (br, 1H, NH)
0.74 (s, 3H, PdMe), 2.27 (s, 3H, NCMe)c
0.76 (s, 3H, PdMe), 2.31 (s, 3H, NCMe)
0.65 (dd, 3H, 3JPH = 6.0, 5.9, PdMe), 4.27
(dd, 2H, 2JPH = 9.3, 3JPH = 1.6, CH2)
0.62 (dd, 3H, 3JPH = 6.3, 6.0, PdMe), 3.60
(d, 2H, 2JPH = 9.0, CH2)
79.8c
79.3
1675m,d
1606me
1659m,d
1604me
1611s
14.0 (d, 1P, CP), 70.1 (d, 1P,
2JPP = 417, NP)
10
2.34 [s, 3H, C(O)Me], 9.55 (br, 1H, NH)
17.2 (d, 1P, CP), 69.0 (d, 1P,
2JPP = 418, NP)
11
—
0.83 (s, 3H, PdMe), 2.31 (s, 3H, MeCN),
4.48 (d, 2H, 2JPH = 11.4, CH2)
0.59 (t, 3H, 3JPH = 5.7, PdMe)
36.0
12a
12b
13
1687,
1611f
1689s,
1612sf
1674s,
1607s
1591s
2.27 [s, 6H, C(O)Me], 8.07 (br, 2H, NH)
2.33 [s, 6H, C(O)Me], 9.08 (br, 2H, NH)
—
60.2
59.0
20.9
0.64 (m, 3H, PdMe)
0.73 (br, 3H, PdMe), 4.48 (s, br, 2H, CH2)
14
2.37 [s, 3H, C(O)Me], 2.98 (d, 3H,
3JPH = 5.4, NMe)g
0.60 (d, 3H, 3JPH = 2.4, PdMe), 2.04 (s, 3H, 98.0g
MeCN)g
15
1665m,
1582sb
1701m,
1589s
2.37 [s, 6H, C(O)Me], 2.95 (virtual t, 6H,
0.47 (t, 3H, 3JPH = 6.0, PdMe)g
77.7g
|3JPH ϩ 5JPH| = 6.0, NMe)g
16
2.20 [s, 3H, C(O)Me], 2.44 [s, 3H,
C(O)Me], 3.06 (br, 3H, NMe), 8.33 (br,
1H, NH)g
0.46 (br, 3H, PdMe)g
49.6 (d, 1P, HNP), 90.7 (d, 1P,
2JPP = 444, MeNP)g
17
1604s
1596s
2.38 [s, 3H, C(O)Me], 10.71 (s, 1H, NH)
0.61 (dd, 3H, 3JPH = 6.5, 5.6, PdMe)
24.8 (d, 1P, PPh3), 70.7 (d, 1P,
2JPP = 405, NP)
cis-18a
2.49 [s, 3H, C(O)Me], 8.75 (br, 1H, NH)
2.45 [s, 3H, C(O)Me], 8.72 (br, 1H, NH)
2.23 [s, 3H, C(O)Me], 10.27 (br, 1H, NH)
2.18 [s, 3H, C(O)Me], 10.01 (br, 1H, NH)
2.51 [s, 3H, C(O)Me], 10.72 (br, 1H, NH)
1.07 (d, 3H, 3JPH = 7.7, PdMe), 3.62 [d, 9H,
3JPH = 13.3, P(OMe)3]
67.8 (d, 1P, NP), 121.3 [d, 1P,
2JPP = 43, P(OMe)3]
trans-18a 1652m
cis-18b 1589s
trans-18b 1608s
cis-19b 1592m
0.86 (dd, 3H, 3JPH = 6.1, 5.9, PdMe), 3.81
[d, 9H, 3JPH = 12.2, P(OMe)3]
0.76 (d, 3H, 3JPH = 7.5, PdMe), 3.43 [d, 9H,
3JPH = 13.3, P(OMe)3]c
68.7 (d, 1P, NP), 119.0 [d, 1P,
2JPP = 603, P(OMe)3]
67.3 (d, 1P, NP), 121.2 [d, 1P,
2JPP = 46, P(OMe)3]c
0.68 (br, 3H, PdMe), 3.54 [d, 9H,
68.3 (d, 1P, NP), 119.7 [d, 1P,
2JPP = 607, P(OMe)3]c
3JPH = 11.4, P(OMe)3]
1.00 (d, 3H, 3JPH = 7.62, PdMe), 1.17
[d, 6H, 3JHH = 3.0, CH(CH3)2], 4.68 [M,
1H, CH((CH3)2)]
67.7 (d, 1P, NP), 111.4 [d, 1P,
2JPP = 36, P(OiPr)3]
trans-19b 1610m
2.44 [s, 3H, C(O)Me], NH not identified
0.88 (dd, 3H, 3JPH = 7.2, 6.6, PdMe), 1.27
[d, 6H, 3JHH = 3.2, CH(CH3)2], 4.68 [m,
1H, CH((CH3)2)]
68.3 (d, 1P, NP), 110.8 [d, 1P,
2JPP = 598, P(OiPr)3]
cis-20b
1589m
2.46 [s, 3H, C(O)Me], 10.74 (br, 1H, NH)
2.26 [s, 3H, C(O)Me], 10.47 (br, 1H, NH)
0.93 (d, 3H, 3JPH = 7.7, PdMe)
69.3 (d, 1P, NP), 110.2 [d, 1P,
2JPP = 46, P(OPh)3]
trans-20b 1613m
0.68 (dd, 3H, 3JPH = 6.7, 5.6, PdMe)
70.5 (d, 1P, NP), 107.5 [d, 1P,
2JPP = 593, P(OPh)3]
a Recorded in CH2Cl2 unless otherwise stated. b Recorded in CDCl3 unless otherwise stated. c Recorded in CD3C(O)CD3. d νCO of Ph2PCH2C(O)R.
e νCO of Ph2PNHC(O)Me. f Recorded as KBr disk. g Recorded in CD2Cl2.
until the temperature of the mixture was raised to 60 ЊC. Then
the solution became cloudy and vapours of chlorotrimethyl-
silane were noticed, which were evacuated under reduced pres-
sure. Upon slow cooling, 1 deposited as a colourless crystalline
material which was recovered by decantation. Its 31P{1H} NMR
(CDCl3) spectrum consisted of two signals at δ 21.6 and 31.1
(ratio 60/40). This could be explained by a tautomeric equi-
librium between the acetamido and the iminol forms 1 and 1Ј,
respectively (Scheme 1), which is supressed in the correspond-
a deshielding effect on the nearby atoms, the 31P{1H} signal of
1Ј is expected to occur at lower field than that of 1. We therefore
assign the signal at δ 21.6 (major tautomer) to the acetamido
ligand 1. In the 1H NMR spectrum the signals due to the CH3
protons of 1 and 1Ј occurred at δ 2.13 and δ 2.30, respectively
(Table 1). The 13C signal of the HN–C᎐O moiety in 1 was
᎐
observed at δ 173.31 and that of N᎐C–OH in 1Ј at δ 174.33, the
᎐
latter showing a 2JPC value of 13 Hz. The suggested tautomeric
equilibrium 1 1Ј appears solvent dependent: in CD2Cl2, the
acetamido form 1 represents more than 75% (60% in CDCl3),
ing N-methyl derivative (see below). The N᎐C bond having
᎐
2206
J. Chem. Soc., Dalton Trans., 2000, 2205–2214